OOIR: Observatory of International Research

Papers

(The H4-Index of CTS-Clinical and Translational Science is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer	173
Issue Information	100
Generalizability in real‐world trials	90
Mitigating ipatasertib‐induced glucose increase through dose and meal timing modifications	89
Intradermal substance P as a challenge agent in healthy individuals	71
ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study	69
Pharmacogenomic landscape of Indian population using whole genomes	64
A Patient Centric Model for Vaso‐Occlusive Crises in Sickle Cell Disease—Outcomes of a Consensus Exercise Conducted Across Patients and Experts	56
Risk factors for the development of sepsis in patients with cirrhosis in intensive care units	53
Evidence of depot‐specific regulation of all‐trans‐retinoic acid biosynthesis in human adipose tissue	45
The impact of skin color and tone on histamine iontophoresis and Doppler flowmetry measurements as a pharmacodynamic biomarker	44
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin	41
Nontraditional Factors Influencing Cardiovascular Disease Risk: Correlation Among Framingham Risk Score, Body Composition Index, and Sleep‐Breathing Monitoring Index	41
Japanese Phase 1 Study for Global Development of Anti‐TL1A Antibody PF‐06480605: A Randomized, Placebo‐Controlled, Single‐Ascending Dose Study	40
Lexicon for blood‐based early detection and screening: BLOODPAC consensus document	39
A comprehensive Thai pharmacogenomics database (TPGxD‐1): Phenotype prediction and variants identification in 942 whole‐genome sequencing data	38
Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community	36
Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization	33
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection	33
Developing a clinical research infrastructure embedded in an academic medicine center that equitably supports future clinician scientists	32
Using partition analysis as a facile method to derive net clearances	32
Issue Information	31
First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome	31
Expanding regulatory science: Regulatory complementarity and reliance	31
	29

From Lab to Clinic: Effect of Academia–Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry	29
Bridging Implementation Gaps in Digital Health: A Translational Research Imperative for Equitable Healthcare Innovation	28
First, Do No Harm: Addressing AI's Challenges With Out‐of‐Distribution Data in Medicine	28